Application 209457
- Type
- ANDA
- Sponsor
- HIKMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ICOSAPENT ETHYL | ICOSAPENT ETHYL | CAPSULE;ORAL | 1GM | No | No |
| 002 | ICOSAPENT ETHYL | ICOSAPENT ETHYL | CAPSULE;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209457-001 | ICOSAPENT ETHYL | ICOSAPENT ETHYL | 1GM | CAPSULE / ORAL | AB | 2020-05-21 | |
| A209457-002 | ICOSAPENT ETHYL | ICOSAPENT ETHYL | 500MG | CAPSULE / ORAL | AB | 2023-03-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209457-001 | AB |
| A209457-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209457-001 | ICOSAPENT ETHYL | 1GM | CAPSULE / ORAL | AB | 2020-05-21 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209457-002 | ICOSAPENT ETHYL | 500MG | CAPSULE / ORAL | AB | 2023-03-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209457-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209457-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Icosapent Ethyl | ICOSAPENT ETHYL | Northstar Rx LLC | 45f8bb41-bdb1-4afc-83ec-9dc69720ee9c | 2026-07-29 | Warnings, Adverse reactions | 209457 ANDA209457 72603-129 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Hikma Pharmaceuticals USA Inc. | e3d38d1d-fbe7-413d-849a-675e7dfa9b0a | 2026-07-09 | Warnings, Adverse reactions | 209457 ANDA209457 0054-0508 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Bryant Ranch Prepack | 07631e74-48e5-46ec-b8db-4b1bcf62d283 | 2026-02-09 | Warnings, Adverse reactions | 209457 ANDA209457 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Bryant Ranch Prepack | 582638e5-9881-409d-a455-041b5ba6892a | 2025-10-21 | Warnings, Adverse reactions | 209457 ANDA209457 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Bryant Ranch Prepack | 0ee78f22-bed2-48f8-9be8-b8f6ceeeaeaf | 2024-12-24 | Warnings, Adverse reactions | 209457 ANDA209457 |
| Icosapent Ethyl | ICOSAPENT ETHYL | Bryant Ranch Prepack | f9c1a6a6-cda4-49ea-97e9-0d3cf5ab5d4c | 2024-01-15 | Warnings, Adverse reactions | 209457 ANDA209457 63629-9311 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0054-0508 | Icosapent Ethyl | Icosapent Ethyl | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 63629-9311 | Icosapent Ethyl | Icosapent Ethyl | Bryant Ranch Prepack | ANDA | Current |
| 63629-9311 | Icosapent Ethyl | Icosapent Ethyl | Bryant Ranch Prepack | ANDA | Current |
| 72603-129 | Icosapent Ethyl | Icosapent Ethyl | Northstar Rx LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 63418 | ORIG | 2020-06-04 |